Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 19,200 shares at $7.31 ($140K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.65 | 6,400 | $43K | 30.4% |
| 2 | $7.31 | 6,400 | $47K | 33.4% |
| 3 | $7.93 | 6,400 | $51K | 36.2% |
| Total | $7.30 avg | 19,200 | $140K | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |